These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 6252575

  • 1. Post-conceptional induction of menses with a single vaginal suppository of (15S)-15-methyl prostaglandin F2 alpha methyl ester.
    Scher J, Jeng DY, Kerenyi TD.
    Prostaglandins; 1980 Sep; 20(3):469-79. PubMed ID: 6252575
    [Abstract] [Full Text] [Related]

  • 2. Termination of early gestation with a single vaginal suppository of (15S)-15-methyl-prostaglandin F2alpha methyl ester.
    Roy S, Brenner PF, Marrs RP, Mishell DR.
    Contraception; 1980 Aug; 22(2):137-52. PubMed ID: 7449379
    [Abstract] [Full Text] [Related]

  • 3. Termination of very early pregnancy by vaginal suppositories-(15S)-15-methyl prostaglandin F2 alpha methyl ester.
    Wan LS, Stiber AJ, Turkel J.
    Contraception; 1981 Dec; 24(6):603-15. PubMed ID: 6173156
    [Abstract] [Full Text] [Related]

  • 4. Termination of early gestation with (15S)-15-methyl prostaglandin F2 alpha methyl ester vaginal suppositories.
    Marrs RP, Brenner PF, Roy S, Mishell DR.
    Contraception; 1981 Dec; 24(6):617-30. PubMed ID: 6173157
    [Abstract] [Full Text] [Related]

  • 5. Termination of early pregnancy by a single-dose 3.0 mg 15-methyl PGF2alpha methyl ester vaginal suppository.
    Mandelin M.
    Prostaglandins; 1978 Jul; 16(1):143-52. PubMed ID: 704921
    [Abstract] [Full Text] [Related]

  • 6. Postconceptional induction of menses with double prostaglandin F2 alpha impact.
    Borten M, Friedman EA.
    Am J Obstet Gynecol; 1984 Dec 15; 150(8):1006-7. PubMed ID: 6507528
    [Abstract] [Full Text] [Related]

  • 7. Menses induction and second-trimester pregnancy termination using a polymeric controlled release vaginal delivery system containing (15S)15-methyl PGF2 alpha methyl ester.
    Bygdeman M, Christenssen N, Gréen K, Vesterqvist O, Roseman TJ, Tuttle ME, Spilman CH.
    Contraception; 1983 Feb 15; 27(2):141-51. PubMed ID: 6303690
    [Abstract] [Full Text] [Related]

  • 8. Termination of early gestation with 9-deoxo-16,16-dimethyl-9-methylene prostaglandin E2.
    Brenner PF, Marrs RP, Roy S, Mishell DR.
    Contraception; 1982 Sep 15; 26(3):261-77. PubMed ID: 6184197
    [Abstract] [Full Text] [Related]

  • 9. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
    Puri CP, Laumas V, Agarwal N, Zoremthangi, Hingorani V, Laumas KR.
    Prostaglandins; 1977 Feb 15; 13(2):363-73. PubMed ID: 847240
    [Abstract] [Full Text] [Related]

  • 10. Vaginal administration of 15-methyl-PGF2 alpha methyl ester for preoperative cervical dilatation. Task force on prostaglandins for fertility regulation. The World Health Organization.
    Contraception; 1981 Mar 15; 23(3):251-9. PubMed ID: 7016432
    [Abstract] [Full Text] [Related]

  • 11. Menstrual regulation with prostaglandin (Pg ONO 802) in Indonesia.
    Agoestina T, Sastrawinata S, Prayitno W, Gonta P.
    Int J Gynaecol Obstet; 1984 Oct 15; 22(5):403-9. PubMed ID: 6151928
    [Abstract] [Full Text] [Related]

  • 12. The effect of a 15(S)-15-methyl prostaglandin F2 alpha (methyl ester) suppository upon termination of early pregnancy.
    Roux JF, Southern E, Gutknecht G.
    Contraception; 1980 Jul 15; 22(1):57-61. PubMed ID: 7418407
    [Abstract] [Full Text] [Related]

  • 13. Early abortion by vaginal prostaglandin suppositories. Blood loss in relation to elimination of serum chorionic gonadotrophin, progesterone and estradiol-17 beta.
    Hamberger L, Nilsson L, Björn-Rasmussen E, Atterfelt P, Wiqvist N.
    Contraception; 1978 Feb 15; 17(2):183-93. PubMed ID: 630888
    [Abstract] [Full Text] [Related]

  • 14. Termination of second trimester pregnancy with a long-acting vaginal pessary containing 15-methyl-PGF2 alpha methyl ester.
    Int J Gynaecol Obstet; 1983 Apr 15; 21(2):159-65. PubMed ID: 6136437
    [Abstract] [Full Text] [Related]

  • 15. Methods to determine success of attempts to terminate early gestation pregnancies with prostaglandin vaginal suppositories.
    Brenner PF, Marrs RP, Roy S, Mishell DR.
    Contraception; 1983 Aug 15; 28(2):111-24. PubMed ID: 6196152
    [Abstract] [Full Text] [Related]

  • 16. Interruption of pregnancy with vaginal suppositories containing 16,16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester.
    Wagatsuma T, Tabuchi T, Tabei T, Kaku R.
    Contraception; 1979 Jun 15; 19(6):591-7. PubMed ID: 487809
    [Abstract] [Full Text] [Related]

  • 17. HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone).
    Nilsson S, Zador G, Nygren KG, Wide L.
    Gynecol Obstet Invest; 1981 Jun 15; 12(4):203-10. PubMed ID: 7250783
    [Abstract] [Full Text] [Related]

  • 18. Menses induction in rhesus monkeys using a controlled-release vaginal delivery system containing (15S) 15-methyl prostaglandin F2 alpha methyl ester.
    Spilman CH, Beuving DC, Forbes AD, Roseman TJ, Bennett RM, Biermacher JJ, Tuttle ME.
    Fertil Steril; 1984 Oct 15; 42(4):638-43. PubMed ID: 6489542
    [Abstract] [Full Text] [Related]

  • 19. The vaginal administration of 9-deoxo-16,16-dimethyl-9-methylene PGE2 for second trimester abortion.
    Ballard CA.
    Contraception; 1981 Aug 15; 24(2):151-7. PubMed ID: 7297067
    [Abstract] [Full Text] [Related]

  • 20. Low-dose prostaglandin E2 analogue for cervical dilatation prior to pregnancy termination.
    Borten M, DiLeo LA, Friedman EA.
    Am J Obstet Gynecol; 1984 Nov 01; 150(5 Pt 1):561-5. PubMed ID: 6496588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.